<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02382354</url>
  </required_header>
  <id_info>
    <org_study_id>AJIRB-MED-CT4-14-417</org_study_id>
    <nct_id>NCT02382354</nct_id>
  </id_info>
  <brief_title>Remifentanil for the I-gel and Laryngeal Mask Airway Insertion</brief_title>
  <official_title>Comparison of the Effect-site Concentration of Remifentanil for Insertion of the I-gel and Laryngeal Mask Airway During Propofol Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ajou University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ajou University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Structural differences of supraglottic airway devices could influence the different
      compressive forces in the oropharyngeal cavities, and require different depth of anesthesia.
      The addition of remifentanil during propofol anesthesia facilitates the insertion of
      laryngeal mask airway (LMA) with minimal adverse hemodynamic disturbances. This study was
      designed to determine the effect-site concentration of remifentanil in 50% of patients (EC50)
      and 95% of patients (EC95) for successful i- gel insertion, and compare those for LMA
      insertion during propofol target-controlled infusion (TCI).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Anesthesia was induced with propofol TCI at the effect-site concentration of 5 μg/ml, and the
      predetermined effect-site concentration of remifentanil was started simultaneously. The
      remifentanil concentration was determined using modified Dixon's up-and-down method (initial
      concentration: 3.0 ng/ml, step size: 0.5 ng/ml). Five minutes later, i- gel or LMA insertion
      was attempted. The response of the patients to the insertion of LMA was classified as either
      'movement' or 'no movement'.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>successful insertion of i-gel and LMA</measure>
    <time_frame>from 5 min after anesthetic induction to 1min after device insertion</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Supraglottic Airways for General Anesthesia</condition>
  <arm_group>
    <arm_group_label>i-gel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>I-gel insertion was attempted during propofol and remifentanil anesthesia .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>laryngeal mask airway</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>LMA insertion was attempted during propofol and remifentanil anesthesia .</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>remifentanil</intervention_name>
    <description>The predetermined effect-site concentration of remifentanil was started using modified Dixon's up-and-down method</description>
    <arm_group_label>i-gel</arm_group_label>
    <arm_group_label>laryngeal mask airway</arm_group_label>
    <other_name>ultiva</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>i-gel</intervention_name>
    <description>I-gel insertion was inserted 5 min after anesthesia induction</description>
    <arm_group_label>i-gel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>laryngeal mask airway</intervention_name>
    <description>laryngeal mask airway insertion was inserted 5 min after anesthesia induction</description>
    <arm_group_label>laryngeal mask airway</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol</intervention_name>
    <description>Anesthesia was induced with propofol target-controlled infusion at the effect-site concentration of 5 μg/ml</description>
    <arm_group_label>i-gel</arm_group_label>
    <arm_group_label>laryngeal mask airway</arm_group_label>
    <other_name>fresofol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I-II patients undergoing general anesthesia for short elective surgery (&lt;2 hr)

        Exclusion Criteria:

          -  G-E reflux

          -  obesity (BMI&gt;30)

          -  anticipated difficult airway
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jong Yeop Kim, MD</last_name>
    <role>Study Director</role>
    <affiliation>Ajou University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ajou University hospital</name>
      <address>
        <city>Suwon</city>
        <zip>443-721</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 25, 2015</study_first_submitted>
  <study_first_submitted_qc>March 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2015</study_first_posted>
  <last_update_submitted>October 13, 2015</last_update_submitted>
  <last_update_submitted_qc>October 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ajou University School of Medicine</investigator_affiliation>
    <investigator_full_name>Jong Yeop Kim</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

